Serum cystatin C is an easy to obtain biomarker for the onset of renal impairment in heart transplant recipients

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 3, 2010, Pages 688-693

  Kniepeiss, Daniela ^a   Wagner, Doris ^a   Wirnsberger, Gerhard ^a   Roller, Regina E ^a   Wasler, Andrä ^a   Iberer, Florian ^a   Tscheliessnigg, Karl Heinz ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; CYSTATIN C; EVEROLIMUS; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; BIOLOGICAL MARKER; CST3 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENOVASCULAR HYPERTENSION; RISK FACTOR; AUSTRIA; BLOOD; CHEMICALLY INDUCED; DRUG COMBINATION; EARLY DIAGNOSIS; HYPERTENSION, RENAL; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RENAL INSUFFICIENCY; RISK ASSESSMENT; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; AUSTRIA; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; DRUG THERAPY, COMBINATION; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, RENAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; RENAL INSUFFICIENCY;

EID: 77956253876     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.03.031     Document Type: Article

References (29)

1. A.H. Wilkinson, and D.J. Cohen Renal failure in the recipients of nonrenal solid organ transplants J Am Soc Nephrol 10 1999 1036 1044
2. D.J. Goldstein, N. Zuech, V. Sehgal, A.D. Weinberg, R. Drusin, and D. Cohen Cyclosporine-associated end-stage nephropathy after cardiac transplantation Transplantation 63 1997 644 668
3. D.K. Satchithananda, J. Parameshwar, and L. Sharples The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience J Heart Lung Transplant 21 2002 651 657
4. A.O. Ojo, P.J. Held, F.K. Port, R.A. Wolfe, A.B. Leichtman, and E.W. Young Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 10 2003 931 940
5. O. Shemesh, H. Golbetz, J.P. Kriss, and B.D. Myers Limitations of creatinine as a filtration marker in glomerulopathic patients Kidney Int 28 1985 830 838
6. P.A. Skluzacek, R.G. Szewc, C.R. Nolan, D.J. Riley, S. Lee, and P.E. Pergola Prediction of GFR in liver transplant candidates Am J Kidney Dis 42 6 2003 1169 1176
7. O. Simonsen, A. Grubb, and H. Thysell The blood serum concentration of cystatin C 8g-trace Scand J Clin Lab Invest 45 1985 97 101
8. J. Kyhse-Andersen, C. Schmidt, G. Nordin, B. Andersson, P. Nilsson-Ehle, and V. Lindström Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate Clin Chem 40 1994 1921 1926
9. B. Jacobsson, H. Lignelid, and U.S. Bergerheim Transthyretin and cystatin C are catabolised in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas Histopathology 26 1995 559 564
10. T. Hayashi, K. Nitta, M. Hatano, M. Nakauchi, and H. Nihei The serum cystatin C concentration measured by particle-enhanced immunonephelometry is well correlated with inulin clearance in patients with various types of glomerulonephritis Nephron 82 1999 90 92
11. B.G. Keevil, E.S. Kilpatrick, S.P. Nichols, and P.W. Maylor Biological variation of cystatin C: implications for the assessment of glomerular filtration rate Clin Chem 44 1998 1535 1539
12. M. Schweiger, A. Wasler, G. Prenner, P. Stiegler, V. Stadlbauer, and M. Schwarz Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients Transplant Immunol 16 2006 46 51
13. A.S. Levey, J.P. Bosch, J.P. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
14. H. Finney, D.J. Newman, W. Gruber, P. Merle, and C.P. Price Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II) Clin Chem 43 1997 1016 1022
15. S.S. Patell, P.L. Kimmel, and A. Singh New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI Semin Nephrol 22 2002 449 458
16. J.E. Storey, J.T. Rowland, D. Basic, and D.A. Conforti A comparison of five clock scoring methods using ROC (receiver operating characteristic) curve analysis Int J Geriatr Psychiatry 16 2001 394 399
17. C. Mariat, E. Alamartine, and A. Afiani Predicting glomerular filtration rate in kidney transplantation: are the K/DOQI-guidelines applicable? Am J Transplant 5 2005 2698 2703
18. R. Hojs, S. Bevc, and R. Ekart Serum cystatin C based equation compared to serum creatinine based equations for estimation of glomerular filtration rate in patients with chronic kidney disease Clin Nephrol 70 2008 10 17
19. P. Delanaye, E. Nellessen, E. Cavalier, G. Depas, S. Grosch, and J.O. Defraigne Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant recipients? Transplantation 83 2007 641 644
20. A. Greenberg, M.E. Thompson, and B.J. Griffith Cyclosporine nephrotoxicity in cardiac allograft patients: a seven-year follow-up Transplantation 50 1990 589 593
21. B.D. Myers, R. Sibley, and L. Newton The long-term course of cyclosporine-associated chronic nephropathy Kidney Int 33 1988 590 600
22. H. Herlitz, and B. Lindelöw Renal failure following cardiac transplantation Nephrol Dial Transplant 15 2000 311 314
23. T. Van Gelder, A.H. Balk, R. Zietse, C. Hesse, B. Mochtar, and W. Weimar Renal insufficiency after heart transplantation: a case-control study Nephrol Dial Transplant 13 1998 2322 2326
24. A.O. Zuckermann, and A. Aliabadi Calcineurin-inhibitor minimization protocols in heart transplantation Transplant Int 22 2009 78 89
25. A.O. Ojo Renal disease in recipients of nonrenal solid organ transplantation Semin Nephrol 27 2007 498 507
26. I.M. Hamour, F. Omar, H.S. Lyster, A. Palmer, and N.R. Banner Chronic kidney disease after heart transplantation Nephrol Dial Transplant 24 2009 1655 1662 2009 Jan 23 [Epub ahead of print]
27. N. Taglieri, D.J. Fernandez-Berges, W. Koenig, L. Consuegra-Sanchez, J.M. Fernandez, N. Robles SIESTA Investigators Plasma cystatin C for the prediction of 1-year cardiac events in Mediterranean patient with non-ST elevation acute coronary syndrome Atherosclerosis 209 2010 300 305 2009 Sep 20 [Epub ahead of print]
28. P.C. Patel, C.R. Ayers, S.A. Murphy, R. Peshock, A. Khera, and J.A. se Lemos Association of cystatin C with left ventricular structure and function: the Dallas Heart Study Circ Heart Fail 2 2009 98 104
29. Q.P. Wang, J.W. Gu, X.H. Zhan, H. Li, and X.H. Luo Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting Ann Clin Biochem 46 Pt 6 2009 495 500